DMD Journal Editor Promotes ASPET Journals at MDO Prague 2024
Dr. Xinxin Ding, Editor-in-Chief of Drug Metabolism and Disposition, recently spoke at The 25th International Symposium on Microsomes and Drug Oxidations about publishing with ASPET’s journals. Dr. Ding discussed the latest journals developments, including the new opportunities with the Society’s partnership with Elsevier. ASPET currently publishes four journals—The Journal of Pharmacology and Experimental Therapeutics, Drug Metabolism and Disposition, Molecular Pharmacology and Pharmacological Reviews. In collaboration with the British Pharmacological Society and Wiley, ASPET publishes Pharmacology Research & Perspectives.
ASPET will launch its new ASPET Discovery journal in 2025. Dr. John Schuetz has been named as its new editor-in-chief and will start his term beginning January 1, 2025.
This new open access journal will publish bi-monthly and will focus on topics on interactions of chemicals with biological systems; drug absorption, distribution, metabolism and disposition; drug delivery; mechanisms of drug actions; pharmacokinetics and pharmacodynamics; toxicology and adverse drug responses; behavioral pharmacology and drugs of abuse; and preclinical, translational, and clinical pharmacology. Also, the journal will cover all types of therapeutic indications, such as cardiovascular, infectious, neurological, and cancerous; all forms of therapeutics, such as small molecules, biologics, and cells; and all research approaches, such as molecular, cellular, and systems pharmacology.
